EurekAlert! Cancer Research - News Releases

News Releases

Updates every hour. Last Updated: 14-Dec-2025 22:11 ET (15-Dec-2025 03:11 GMT/UTC)

Duke and Duke-NUS’ joint cross-population research to uncover "East-West" differences in disease and care

Duke-NUS Medical School
Grant and Award Announcement

By comparing clinical cohorts and populations from Singapore and the US, researchers will study infectious diseases, corneal disorders, liver transplant outcomes, diabetes and lung cancer to uncover insights that drive disease and treatment differences across Asian and non-Asian populations.

Scientists to ‘spy’ on cancer- immune cell interactions using quantum technology breakthrough

Heriot-Watt University
Grant and Award Announcement

A revolutionary quantum sensing project that could transform cancer treatment by tracking how immune cells interact with tumours has been awarded a prestigious £2 million Future Leaders Fellowship.

The four-year fellowship, funded by UK Research and Innovation, focuses on a critical problem: immune cells often fail when they encounter cancer tissue because the tumour environment disrupts their metabolism. The pathbreaking project could enable the development of improved patient-tailored cancer therapies and provide tools for earlier diagnosis and evaluation of anti-cancer drugs.

Funder: UK Research and Innovation

Invisible indoor threats: emerging household contaminants and their growing risks to human health

Biochar Editorial Office, Shenyang Agricultural University
Peer-Reviewed Publication

Indoor dust, air and everyday products are exposing people to a growing mix of “new contaminants” inside homes, schools and workplaces, according to a new perspective published in the journal New Contaminants. The authors warn that these emerging chemicals may quietly increase the risk of heart disease, cancer and developmental problems while remaining largely unregulated and poorly monitored indoors.

Adding antibody treatment to chemo boosts outcomes for children with rare cancer

University of Birmingham
Peer-Reviewed Publication

Newly published research in the Journal of Clinical Oncology reports on a phase 2 clinical trial that finds that children with a rare form of cancer called neuroblastoma which hasn’t responded to initial treatment or that has relapsed may benefit from adding antibody treatment to usual chemotherapy.

Journal: Journal of Clinical Oncology

Indoor tanning makes youthful skin much older on a genetic level

University of California - San Francisco
Peer-Reviewed Publication

Tanning bed users are known to have a higher risk of skin cancer, but for the first time researchers have found that young indoor tanners undergo genetic changes that can lead to more mutations in their skin cells than people twice their age.

Journal: Science Advances
Funder: NIH/National Cancer Institute, NIH/National Institute of Arthritis and Musculoskeletal and Skin Diseases, U.S. Department of Defense, Melanoma Research Alliance

Unique bond identified as key to viral infection speed

Penn State
Peer-Reviewed Publication

Viruses are typically described as tiny, perfectly geometric shells that pack genetic material with mathematical precision, but new research led by scientists at Penn State reveals a deliberate imbalance in their shape that helps them infect their hosts.

Journal: Science Advances
Funder: NIH/National Institutes of Health

Tanning beds triple melanoma risk, potentially causing broad DNA damage

Northwestern University
Peer-Reviewed Publication

Tanning bed use is tied to almost a threefold increase in melanoma risk, and for the first time, scientists have shown how these devices cause melanoma-linked DNA damage across nearly the entire skin surface, reports a new study led by Northwestern Medicine and University of California, San Francisco.

Journal: Science Advances

Germline pathogenic variants among women without a history of breast cancer

JAMA Network
Peer-Reviewed Publication

About The Study: In this secondary analysis of the WISDOM trial, a randomized clinical trial that enrolled women without breast cancer ages 40 to 74, criteria-independent genetic testing in a pragmatic trial identified a substantial number of women with clinically actionable results, many of whom would not have qualified for genetic testing under current guidelines. These findings support broader access to genetic testing as part of personalized breast cancer risk assessment.

Journal: JAMA Internal Medicine

Innovating to serve the world: UCLA researchers elected to National Academy of Inventors

University of California - Los Angeles Health Sciences
Grant and Award Announcement

Maher El-Kady, whose work on energy solutions promises a cleaner, more sustainable and more accessible energy future, and Dr. Dennis Slamon, whose groundbreaking innovations in breast cancer treatment have benefited millions around the globe, today join more than 30 other UCLA researchers who have received the honor — the highest professional distinction awarded to inventors.

Risk-based vs annual breast cancer screening / the WISDOM randomized clinical trial

JAMA Network
Peer-Reviewed Publication

About The Study: In a randomized clinical trial, researchers found risk-based breast cancer screening was as safe as annual screening for detecting advanced cancers but did not reduce breast biopsy rates. Corresponding author Laura J. Esserman, MD, MBA, of the University of California, San Francisco, will present the study at the San Antonio Breast Cancer Symposium.

Journal: JAMA

1
2
3